Search
Returning search results with filters:
Remove filter for
Issue: Health products
Remove filter for
Last updated: April 2024
Remove filter for
Last updated: 2024
Remove filter for
Type: Recall
Clear all
Search filters
Type
Audience
Category
Issue
Last updated
Recall class
Displaying 1 - 7 of 7 items.
Miracle Reds: missing risk statement
RecallHealth product recall | 2024-04-23
PMS-Duloxetine 60 mg: Exceeds acceptable interim intake limit for N-nitroso-duloxetine (NDLX)
RecallHealth product recall | 2024-04-17
PMS-Duloxetine 30 mg: Exceeds acceptable interim intake limit for N-nitroso-duloxetine (NDLX)
RecallHealth product recall | 2024-04-17
I-131 Diagnostic Capsule: Affected lots may have decreased thyroid uptake.
RecallHealth product recall | 2024-04-17
JAMP-Guanfacine XR 4 mg: Foreign matter
RecallHealth product recall | 2024-04-10
Honeywell Eyesaline Emergency Eyewash: deficiencies in Good Manufacturing Practices (GMP)
RecallHealth product recall | 2024-04-04
JAMP-Rabeprazole 20 mg: Affected lot may contain JAMP-Rabeprazole 10 mg
RecallHealth product recall | 2024-04-02